Literature DB >> 24380782

Variants in C-reactive protein and IL-6 genes and susceptibility to obstructive sleep apnea in children: a candidate-gene association study in European American and Southeast European populations.

Athanasios G Kaditis1, David Gozal2, Abdelnaby Khalyfa2, Leila Kheirandish-Gozal2, Oscar Sans Capdevila3, Konstantinos Gourgoulianis4, Emmanouel I Alexopoulos4, Konstantinos Chaidas4, Rakesh Bhattacharjee2, Jinkwan Kim2, Paraskevi Rodopoulou5, Elias Zintzaras6.   

Abstract

BACKGROUND: Preliminary evidence indicates that variants of the C-reactive protein (CRP) and IL-6 genes might be associated with the presence of obstructive sleep apnea (OSA) in childhood. Thus a candidate-gene association study was conducted to investigate the association of four variants of the CRP gene (1444C/T, -717T/C, 1861C/T, and 1919A/T) and two variants of the IL-6 gene (-174G/C and 597G/A) with OSA in a cohort of European American and Greek children.
METHODS: The genetic risk effects were estimated based on the odds ratio (OR) of the allele contrast and the generalized odds ratio (ORG), which is a model-free approach. The mode of inheritance was assessed using the degree of dominance index. The impact of haplotypes was also examined.
RESULTS: In the American population, the allele contrast and the model-free approach produced significant ORs for the CRP 1444C/T variant (OR, 3.82 [95% confidence interval {CI}, 1.91-7.63] and ORG, 4.37 [95% CI, 1.96-9.76]), respectively, and the mode of inheritance was recessiveness of allele T. Significance was also shown for the CRP 1919A/T variant (OR, 2.45 [95% CI, 1.23-4.85] and ORG, 2.76 [95% CI, 1.26-6.03]) with the mode of inheritance being nondominance of allele T. For the IL-6-174G/C variant, there was an indication of recessiveness of allele C. Finally, the IL-6-174C/IL-6 597A haplotype was associated with OSA. In the Greek population, no association was detected for any variant or haplotype.
CONCLUSIONS: Genetic variation in the IL-6/CRP pathway was associated with increased risk for OSA in European American children and may account for the higher CRP levels in the context of pediatric OSA compared to Greek children.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C-reactive protein; Genetic association; Inflammation; Interleukin-6; Obstructive sleep apnea; Obstructive sleep-disordered breathing

Mesh:

Substances:

Year:  2013        PMID: 24380782      PMCID: PMC3940266          DOI: 10.1016/j.sleep.2013.08.795

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  55 in total

1.  No adjustments are needed for multiple comparisons.

Authors:  K J Rothman
Journal:  Epidemiology       Date:  1990-01       Impact factor: 4.822

2.  SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci.

Authors:  Yong Yong Shi; Lin He
Journal:  Cell Res       Date:  2005-02       Impact factor: 25.617

3.  Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome.

Authors:  R L Riha; P Brander; M Vennelle; N McArdle; S M Kerr; N H Anderson; N J Douglas
Journal:  Eur Respir J       Date:  2005-10       Impact factor: 16.671

Review 4.  What's wrong with Bonferroni adjustments.

Authors:  T V Perneger
Journal:  BMJ       Date:  1998-04-18

5.  Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis.

Authors:  Lu Qi; Rob M van Dam; James B Meigs; JoAnn E Manson; David Hunter; Frank B Hu
Journal:  Hum Mol Genet       Date:  2006-04-27       Impact factor: 6.150

6.  Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6.

Authors:  J V Castell; M J Gómez-Lechón; M David; R Fabra; R Trullenque; P C Heinrich
Journal:  Hepatology       Date:  1990-11       Impact factor: 17.425

7.  Morning levels of C-reactive protein in children with obstructive sleep-disordered breathing.

Authors:  Athanasios G Kaditis; Emmanouel I Alexopoulos; Efthimia Kalampouka; Eleni Kostadima; Anastasios Germenis; Elias Zintzaras; Konstantinos Gourgoulianis
Journal:  Am J Respir Crit Care Med       Date:  2004-11-19       Impact factor: 21.405

8.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

9.  The familial aggregation of obstructive sleep apnea.

Authors:  S Redline; P V Tishler; T D Tosteson; J Williamson; K Kump; I Browner; V Ferrette; P Krejci
Journal:  Am J Respir Crit Care Med       Date:  1995-03       Impact factor: 21.405

10.  Allelic spectrum of the natural variation in CRP.

Authors:  Dana C Crawford; Qian Yi; Joshua D Smith; Cynthia Shephard; Michelle Wong; Laura Witrak; Robert J Livingston; Mark J Rieder; Deborah A Nickerson
Journal:  Hum Genet       Date:  2006-03-21       Impact factor: 4.132

View more
  18 in total

Review 1.  The role inflammatory response genes in obstructive sleep apnea syndrome: a review.

Authors:  Francisco Fábio Ferreira de Lima; Diego R Mazzotti; Sergio Tufik; Lia Bittencourt
Journal:  Sleep Breath       Date:  2015-07-23       Impact factor: 2.816

Review 2.  Pediatric OSA Syndrome Morbidity Biomarkers: The Hunt Is Finally On!

Authors:  Leila Kheirandish-Gozal; David Gozal
Journal:  Chest       Date:  2016-10-06       Impact factor: 9.410

Review 3.  Cutting-edge technologies for diagnosis and monitoring of snoring in children.

Authors:  Ioannis Vlastos; Ioannis Athanasopoulos
Journal:  World J Clin Pediatr       Date:  2016-02-08

4.  5-HTR2A and IL-6 polymorphisms and obstructive sleep apnea-hypopnea syndrome.

Authors:  Wenjuan Wu; Zhijun Li; Tingyu Tang; Jinyan Wu; Fang Liu; Liang Gu
Journal:  Biomed Rep       Date:  2015-12-16

Review 5.  OSA and Cardiovascular Risk in Pediatrics.

Authors:  David F Smith; Raouf S Amin
Journal:  Chest       Date:  2019-02-18       Impact factor: 9.410

6.  The effect of continuous positive airway pressure treatment on inflammatory parameters and periostin levels in patients with obstructive sleep apnea syndrome.

Authors:  Fatma Tosun; Cenk Babayiğit; Nursel Dikmen; Serdar Doğan; Emre Dirican
Journal:  Sleep Breath       Date:  2022-04-27       Impact factor: 2.816

7.  C-reactive Protein as a Potential Biomarker of Residual Obstructive Sleep Apnea Following Adenotonsillectomy in Children.

Authors:  Rakesh Bhattacharjee; Leila Kheirandish-Gozal; Athanasios G Kaditis; Stijn L Verhulst; David Gozal
Journal:  Sleep       Date:  2016-02-01       Impact factor: 5.849

8.  Roles of interleukin (IL)-6 gene polymorphisms, serum IL-6 levels, and treatment in obstructive sleep apnea: a meta-analysis.

Authors:  Anyuan Zhong; Xiaolu Xiong; Minhua Shi; Huajun Xu
Journal:  Sleep Breath       Date:  2015-11-13       Impact factor: 2.816

9.  Nutrigenetic genotyping study in relation to Sleep Apnea Clinical Score.

Authors:  K Gkouskou; I M Vlastos; D Chaniotis; A Markaki; K Choulakis; E Prokopakis
Journal:  Sleep Breath       Date:  2018-10-17       Impact factor: 2.816

10.  Effects of adenotonsillectomy on plasma inflammatory biomarkers in obese children with obstructive sleep apnea: A community-based study.

Authors:  L Kheirandish-Gozal; A Gileles-Hillel; M L Alonso-Álvarez; E Peris; R Bhattacharjee; J Terán-Santos; J Duran-Cantolla; D Gozal
Journal:  Int J Obes (Lond)       Date:  2015-03-24       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.